检索结果 - Sanjiv Modi

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium

    Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium 由 Sonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin, Anas Younes, Scott E. Smith, Patrick J. Stiff, Eric P. Lester, Sanjiv Modi, L. Austin Doyle, Everett E. Vokes, Barbara Pro

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer

    An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer 由 Walter M. Stadler, David J. Vaughn, Guru Sonpavde, Nicholas J. Vogelzang, Scott T. Tagawa, Daniel P. Petrylak, Peter J. Rosen, Chia‐Chi Lin, John F. Mahoney, Sanjiv Modi, Peter P. Lee, Marc S. Ernstoff, Wu‐Chou Su, Alexander I. Spira, Korinna Pilz, Richard Vinisko, Charles Schloss, Holger Fritsch, Charles Zhao, Michael A. Carducci

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: